|
?:authorAffiliation
|
-
[\'Li Ka Shing Knowledge Institute of St Michael\'s Hospital, Toronto, Ontario, Canada.\', \'ICES, Toronto, Ontario, Canada.\', \'Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.\', \'Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.\', \'Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Collaboration for Outcomes Research and Evaluation, Vancouver, British Columbia, Canada.\', \'Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.\', \'Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.\', \'Women\'s College Hospital, Toronto, Ontario, Canada.\', \'Lived Experience Advisory Group, Ontario Drug Policy Research Network, Toronto, Ontario, Canada.\', \'Department of Family and Community Medicine, St Michael\'s Hospital, Toronto, Ontario, Canada.\', \'Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}